Big Move For Frequency Therapeutics, Inc.
Frequency Therapeutics, Inc. (FREQ:NASDAQ) soared at $0.71, a gain of 77.5%. On Fri, Jul 14, 2023, FREQ:NASDAQ hit a New 2-Week High of $0.71. The stock got featured on our News Catalysts scanner on Fri, Jul 14, 2023 at 07:19 AM in the 'AGREEMENT' category. From Fri, Jun 30, 2023, the stock recorded 66.67% Up Days and 60.00% Green Days
About Frequency Therapeutics, Inc. (FREQ:NASDAQ)
Frequency Therapeutics Inc is a clinical-stage biotechnology company focused on harnessing the body's innate biology to repair or reverse damage caused by degenerative diseases. Its Progenitor Cell Activation approach uses combinations of molecules to activate progenitor cells within the body to create functional tissue. Its product candidate FX-322 is being developed for treating sensorineural hearing loss.
Top 10 Gainers:
- Kaspien Holdings Inc. (KSPN:NASDAQ), 87.31%
- Frequency Therapeutics, Inc. (FREQ:NASDAQ), 77.48%
- EdtechX Holdings Acquisition Corp. (EDTX:NASDAQ), 46.29%
- PainReform Ltd. (PRFX:NASDAQ), 40.87%
- Knightscope Inc. (KSCP:NASDAQ), 37.58%
- Chijet Motor Company Inc. (CJET:NASDAQ), 35.35%
- Peak Bio Inc Com (PKBO:NASDAQ), 29.23%
- Baosheng Media Group Holdings Limited (BAOS:NASDAQ), 28.75%
- Canoo Inc. (GOEV:NASDAQ), 27.31%
- Envirotech Vehicles Inc. (EVTV:NASDAQ), 26.25%